Effects of 17 beta-estradiol on circulating adhesion molecules

Area of Science:

• Endocrinology
• Immunology
• Cardiovascular Science

Background:

• Estrogen's cardioprotective effects are partly attributed to modulation of endothelial function.
• Adhesion molecules (ELAM-1, ICAM-1, VCAM-1) play roles in atherosclerosis and inflammation.
• The impact of 17 beta-estradiol (E2) on these molecules in men requires clarification.

Purpose of the Study:

• To investigate the effects of E2 on serum levels of circulating adhesion molecules (ELAM-1, ICAM-1, VCAM-1) in healthy male volunteers.
• To assess the time course of E2's impact on adhesion molecules, cortisol, blood counts, and leukocyte surface markers.
• To determine if E2's effects on adhesion molecules contribute to its antiatherogenic properties.

Main Methods:

• Single intramuscular injection of 10 mg E2 valerate in healthy male volunteers.
• Measurement of serum adhesion molecules (ELAM-1, ICAM-1, VCAM-1) at various time points.
• Analysis of differential blood counts and leukocyte surface antigen expression (CD11a/CD18, CD3, CD4, CD19, CD25).

Main Results:

• A marginal, non-significant decrease in ICAM-1 was observed 96 hours post-E2 injection.
• No consistent or time-dependent effect of E2 on circulating adhesion molecules was detected.
• A significant 2.3-fold increase in circulating neutrophils was observed after E2 treatment (P = 0.0008).

Conclusions:

• E2's effect on circulating adhesion molecules in men is not statistically distinguishable from placebo variability.
• Modulation of adhesion molecules is unlikely to mediate E2's antiatherogenic and cardioprotective effects.
• The E2-induced increase in neutrophils warrants further investigation for its physiological implications.